M&A

M&A

BDR Pharma looking to buy majority stake in Belarus state-owned drug unit

Economic Times  

BDR Pharma, a Mumbai-based drugmaker that raised around INR 750 crore earlier this year from Multiples Alternate Asset Management, is gearing up for geographic expansion that includes plans to acquire controlling stake in a Belarus government-owned pharma unit. The Belarus facility can manufacture both formulations and active pharmaceutical ingredients (APIs). BDR will be investing USD 13 million in the Belarus facility. In addition, it is also investing in setting up a formulation manufacturing unit in Algeria to make anti-cancer medication at an investment of USD 12 million.